Tevogen Bio Holdings
TVGN
51 hedge funds and large institutions have $1.68M invested in Tevogen Bio Holdings in 2025 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 23 increasing their positions, 10 reducing their positions, and 10 closing their positions.
130% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 10
0% more ownership
Funds ownership: 0.05% → 0.05% (+0%)
6% less funds holding
Funds holding: 54 → 51 (-3)
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
56% less capital invested
Capital invested by funds: $3.78M → $1.68M (-$2.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$79.3K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$68K |
| 3 |
Morgan Stanley
New York
|
+$64.3K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$29K |
| 5 |
HF
HRT Financial
New York
|
+$27.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$186K |
| 2 |
Creative Planning
Overland Park,
Kansas
|
-$39.3K |
| 3 |
CUAMC
China Universal Asset Management Company
Shanghai,
China
|
-$27.1K |
| 4 |
Bank of New York Mellon
New York
|
-$12.3K |
| 5 |
ProShare Advisors
Bethesda,
Maryland
|
-$9.51K |
TVGN Hedge Fund Activity: Q4 2025 in Review
51 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Tevogen Bio Holdings (TVGN) for Q4 2025, worth a combined $1.68M — down 56% from $3.78M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of TVGN and 7 opened new positions — a net loss of 3 holders — while 10 trimmed existing stakes and 23 added.
The largest buyer was Goldman Sachs, adding an estimated $79.3K. The largest seller was BlackRock, cutting an estimated $186K.
- 51 institutional investors held Tevogen Bio Holdings (TVGN) as of Q4 2025, down from 54 in Q3 2025.
- Funds reported $1.68M of Tevogen Bio Holdings stock for Q4 2025, down 56% quarter-over-quarter.
- 7 funds opened new Tevogen Bio Holdings positions in Q4 2025 and 10 closed out, a net change of -3 holders.
- The largest Tevogen Bio Holdings buyer in Q4 2025 was Goldman Sachs, an estimated $79.3K added.
- The largest Tevogen Bio Holdings seller in Q4 2025 was BlackRock, an estimated $186K sold.
Based on aggregated 13F filings for Q4 2025.